There are 2867 resources available
Is germline testing needed and does it impact treatment decisions?
Presenter: Elena Castro Marcos
Session: Using molecular data that impacts clinical practice
Resources:
Slides
Webcast
Drugging KRAS in CRC: where do we stand?
Presenter: Rodrigo Dienstmann
Session: Are novel immunotherapeutics and targeted treatments going to transform the management of CRC?
Resources:
Slides
Webcast
The role of B cell/TLS
Presenter: Catherine Sautes-Fridman
Session: How the tumour microenvironment affects outcome and therapy response?
Resources:
Slides
Webcast
Molecular classification of aggressive lymphoma
Presenter: Fabrice Jardin
Session: How diagnostic tools impact therapy of haematological malignancies
Resources:
Slides
Webcast
The impact of COVID-19 on advocacy networks
Presenter: Lydia Makaroff
Session: The impact of COVID-19 on patients with cancer: Lessons learnt and pathway for the future
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Updates in the standard of care of metastatic breast cancer
Resources:
Webcast
Clinical development of next generation DDR agents for molecularly-selected tumours
Presenter: Timothy Yap
Session: Exploiting synthetic lethality: The next generation
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Ultra-rare sarcoma: Navigating an endless sea
Resources:
Webcast
Invited Discussant LBA29, 517O and 518O
Presenter: Jonathan Ledermann
Session: Proffered Paper session: Gynaecological cancers
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: CNS tumours
Resources:
Webcast